SEOUL, July 25 (Korea Bizwire) — A tens of thousands of COVID-19 vaccine doses, intended for free vaccinations for the public, have been scrapped after reaching their expiration date, data showed Monday. According to a report from the Korea Disease Control and Prevention Agency (KDCA) submitted to Rep. Jung Choun-sook of the Democratic Party, some [...]
SEOUL, July 4 (Korea Bizwire) — People who have received COVID-19 vaccines are less likely to contract other major diseases compared to those who have not been vaccinated, a study showed Monday. A research team from the Korea National Institute of Health, under the Korea Disease Control and Prevention Agency, tracked approximately 12.3 million patients [...]
SEOUL, May 30 (Korea Bizwire) — SK bioscience Co., a pharmaceutical affiliate of South Korea’s SK Group, said Tuesday its COVID-19 vaccine SKYCovione has won approval from British authorities. The British Medicines and Healthcare products Regulatory Agency has approved the Korean vaccine for use as a primary vaccination in those aged 18 and over in [...]
SEOUL, Sept. 2 (Korea Bizwire) — SKYCovione, South Korea’s first homegrown COVID-19 vaccine developed by SK Bioscience Co., has been proven to be effective against coronavirus omicron subvariants when administered as a booster shot, a state-run research center said Friday. The Center for Infectious Disease Research (CIDR) said it has confirmed through research SKYCovione’s efficacy [...]
SEOUL, July 4 (Korea Bizwire) — South Korea has decided to send 40,000 doses of Moderna’s COVID-19 vaccine to Guyana, Seoul’s foreign ministry said Monday, in a move to support the South American country’s fight with the virus. The doses are scheduled to be sent later Monday night and expected to arrive in Guyana’s capital [...]
SEOUL, June 29 (Korea Bizwire) — South Korea on Wednesday approved the use of SKYCovione, the country’s first homegrown COVID-19 vaccine developed by SK Bioscience Co., taking a major step toward achieving vaccine sovereignty in the fight against the pandemic. The Ministry of Food and Drug Safety (MFDS) said it approved the use of SKYCovione, [...]
SEOUL, June 27 (Korea Bizwire) — South Korea’s first COVID-19 vaccine candidate, developed by SK Bioscience Co., has received an approval recommendation from a government advisory group of pharmaceutical experts, officials said Monday, pushing the vaccine candidate one step closer to commercial launch. The Ministry of Food and Drug Safety said GBP510, the vaccine candidate [...]
SEOUL, May 24 (Korea Bizwire) — North Korea’s state-controlled media carried reports Tuesday questioning the usefulness of COVID-19 vaccines, as the secretive nation has claimed progress in efforts to control the virus outbreak. The North’s latest stance may suggest a dimmer prospect of accepting the international community’s existing offers of vaccine aid, including Washington’s stated [...]
New York, April 7 (Korea Bizwire) – MedAccess, the Open Society Foundations, and Gavi, the Vaccine Alliance today announced a new partnership to create a Risk Sharing Facility to help countries procure additional COVID-19 vaccine doses, including variant-adapted doses in response to risks and shocks. The $200 million facility is designed to enable countries to protect [...]
SOUTHBOROUGH, Mass., March 24 (Korea Bizwire) – Virtusa Corporation today announced that its Virtusa Vax Manager is available to provide businesses with an easy way to track employee vaccination status. The COVID-19 vaccine tracker and return to office capabilities of Virtusa Vax Manager can be built rapidly, and is easily configurable on technology from Pegasystems, the software company that [...]